Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TP53 | P04637 | 4/20 | 0.40 |
| ▸ | MAPT | P10636 | 2/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | P2RX7 | Q99572 | 1/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
| ▸ | MC4R | P32245 | 6/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | PTGER1 | P34995 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7660068 | 0.86 | TLR7 (0.42) | TP53MAPTP2RX7POLBKDM4E | |
| SCHEMBL7667892 | 0.86 | POLB (0.38) | TP53MAPTLMNAP2RX7POLB | |
| SCHEMBL7674200 | 0.84 | TP53 (0.40) | TP53MAPTLMNAP2RX7POLB | |
| SCHEMBL7669141 | 0.82 | TP53 (0.44) | TP53MAPTLMNAKDM4ESMN1; SMN2 | |
| SCHEMBL7671615 | 0.81 | HPGD (0.41) | TP53MAPTLMNAP2RX7KDM4E | |
| SCHEMBL7671400 | 0.81 | TP53 (0.41) | TP53MAPTLMNAPOLBSMN1; SMN2 | |
| SCHEMBL7669474 | 0.80 | ROCK2 (0.40) | TP53MAPTLMNAP2RX7SMN1; SMN2 | |
| SCHEMBL7689852 | 0.79 | TP53 (0.37) | TP53MAPTLMNAP2RX7 | |
| SCHEMBL7672496 | 0.79 | TP53 (0.41) | TP53MAPTLMNAKDM4E | |
| SCHEMBL7674096 | 0.79 | KCNH2 (0.38) | TP53MAPTLMNAPOLBSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12439917-B2 | Method for controlling phakopsora pachyrhizi having resistance against QoI fungicide | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2025-10-14 | — | — | US | disclosed |
| US-20230127143-A1 | METHOD FOR CONTROLLING PHAKOPSORA PACHYRHIZI HAVING RESISTANCE AGAINST QoI FUNGICIDE | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2023-04-27 | — | — | US | disclosed |
| WO-2021153782-A1 | METHOD FOR CONTROLLING PHAKOPSORA PACHYRHIZI HAVING RESISTANCE AGAINST QoI FUNGICIDE | 住友化学株式会社 | 2021-08-05 | — | — | WO | disclosed |
| US-6489487-B1 | AGRICULTURAL OR HORTICULTURAL FUNGICIDES | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2002-12-03 | — | — | US | disclosed |
| EP-1103548-A1 | TRIAZOLONE DERIVATIVES, USE THEREOF, AND INTERMEDIATE THEREFOR | SUMITOMO CHEMICAL COMPANY LIMITED (JP) | 2001-05-30 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230127143-A1 | METHOD FOR CONTROLLING PHAKOPSORA PACHYRHIZI HAVING RESISTANCE AGAINST QoI FUNGICIDE | CYC1, COX5B, SQOR | TP53 2227/4885MAPT 1164/4885LMNA 2649/4885 |
| US-12439917-B2 | Method for controlling phakopsora pachyrhizi having resistance against QoI fungicide | CYC1, COX5B, SQOR | TP53 2227/4885MAPT 1164/4885LMNA 2649/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.